Atorvastatin Reduces Plasma Inflammatory and Oxidant Biomarkers in Patients With Risk of Atherosclerotic Cardiovascular Disease
ViewSix months azithromycin treatment in COPD patients reduces frequency of exacerbations and dalays time to first exacerbation
ViewCefpodoxime Demonstrates Safety and Efficacy as Empirical Treatment for Adult Patients with Acute Upper Respiratory Tract Infections (URTIs)
ViewOlmesartan-Based Treatment Improves Adherence to Treatment and Reduces Economic Costs of Hypertension
ViewCorrelation of compliance to statin therapy with lipid profile in dyslipidemic patients
ViewGliclazide therapy influences peripheral blood monocytes in patients with type 2 diabetes mellitus (T2DM)
ViewEfficacy of lower doses of pioglitazone after stroke or transient ischemic attack in patients with insulin resistance
ViewAzithromycin for Poorly Controlled Asthma in Children: A Randomized Controlled Trial
ViewEffect of a Fixed-dose Combination of Telmisartan/S-amlodipine on Circadian Blood Pressure Compared with Telmisartan Monotherapy: TENUVA-BP study
View